1-4 of 4
protein-serine-threonine kinases
Close
Sort by
Journal Articles

The role of aurora A and polo-like kinases in high-risk lymphomas

Clinical Trials & Observations
Carlos Murga-Zamalloa, Kedar V. Inamdar, Ryan A. Wilcox
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1778–1787.
https://doi.org/10.1182/bloodadvances.2019000232
Published: 2019
Journal Articles

Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma

Ilyas Sahin, Yawara Kawano, Romanos Sklavenitis-Pistofidis, Michele Moschetta, Yuji Mishima, Salomon Manier, Antonio Sacco, Ruben Carrasco, Rafael Fonseca, Aldo M. Roccaro, Thomas Witzig, Irene M. Ghobrial
Journal: Blood Advances
Blood Adv (2019) 3 (7): 995–1002.
https://doi.org/10.1182/bloodadvances.2018028456
Published: 2019
Includes: Supplemental data
Journal Articles

Complex karyotype AML displays G2/M signature and hypersensitivity to PLK1 inhibition

Céline Moison, Vincent-Philippe Lavallée, Clarisse Thiollier, Bernhard Lehnertz, Isabel Boivin, Nadine Mayotte, Yves Gareau, Mélanie Fréchette, Valérie Blouin-Chagnon, Sophie Corneau, Sylvie Lavallée, Sébastien Lemieux, Anne Marinier, Josée Hébert, Guy Sauvageau
Journal: Blood Advances
Blood Adv (2019) 3 (4): 552–563.
https://doi.org/10.1182/bloodadvances.2018028480
Published: 2019
Includes: Supplemental data
Journal Articles

The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy

Suhu Liu, Anna E. Marneth, Gabriela Alexe, Sarah R. Walker, Helen I. Gandler, Darwin Q. Ye, Katherine Labella, Radhika Mathur, Patricia A. Toniolo, Michelle Tillgren, Prafulla C. Gokhale, David Barbie, Ann Mullally, Kimberly Stegmaier, David A. Frank
Journal: Blood Advances
Blood Adv (2018) 2 (23): 3428–3442.
https://doi.org/10.1182/bloodadvances.2018016733
Published: 2018
Includes: Supplemental data